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Comparative Calcification of Valve Leaflet Materials: Lotus Valve Material Compared to
a Surgical Valve Control
Crystal Anderson-Cunanan, Katherine Fazackerley, Thomas Herbst, Barbara Huibregtse
Boston Scientiﬁc Corporation, Natick, MA
Background: Comparative assessment of calciﬁcation of leaﬂet materials in the rat
subcutaneous model allows assessment of processes of tissue treatment of leaﬂet ma-
terials. Calciﬁcation is the leading cause of long-term failure of pericardial valves. We
report the results of comparison of the Lotus valve leaﬂet tissue to that of the approved
Mitroﬂow valve.
Methods: 18 animals were implanted for 30 (N¼5), 60 (8) or 90 (5) days. Each
animal was implanted subcutaneously with 6 tissue disks per animal (3 test disks/3
control disks). Following euthanasia, the implant sites were ﬁxed, processed, and
stained with hematoxylin and eosin (MEDSTAR&E), Masson’s Trichrome (MT)
and von Kossa (VK) for light microscopy. A subset of samples were analyzed for
calcium content and reported as ug/mg dry tissue weight. (Table)
Results: Of the 108 total tissue disks implanted, 75 were analyzed for calcium
content, (Table), with remainder for histologic analysis. No microscopically detectable
calciﬁcation was observed in the Lotus disk at 30, 60 or 90 days. The Control disks
showed mild to severe calciﬁcation at 30, 60 and 90 days.
Conclusion: Implantation of the Lotus and Control articles showed a lack of calci-
ﬁcation in the Lotus group at all time points whereas the Controls showed mild to
severe calciﬁcation at 30, 60 and 90 days. Average calcium content was lower for the
Lotus valve. The Lotus valve tissue has less potential to calcify compared to the
Control material.
Table. Biochemical Analysis of Tissue Calcium ContentTimepoint Sample SizeCalciumAverage + SD Max Min30 Day 20Lotus 9 1.09  0.13 1.30 0.93
Mitroﬂow (control) 11 64.95  30.18 121.00 27.70
60 Days 32Lotus 20 1.14  0.12 1.51 0.98
Mitroﬂow (control) 12 109.66  57.51 169.00 2.30
90 Days 23Lotus 11 1.46  0.27 2.05 1.14
Mitroﬂow (control) 12 170.25  20.35 204.00 145.00
Total Samples 75Mitral Valve
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Immediate Echocardiographic and In-Hospital Results of Percutaneous Transvenous
Mitral Commissurotomy in Juvenile Rheumatic Mitral Stenosis
Touﬁqur Rahman
National Institute of Cardiovascular Diseases, Dhaka, DHAKA, Bangladesh
Background: Percutaneous Transvenous mitral Commissurotomy (PTMC) is an
established non-surgical modality for the treatment of severe rheumatic mitral valve
stenosis. Until the mid-1980s, surgical closed or open commissurotomy was the onlyavailable treatment. However, mitral valve surgery in children and adolescents, in
addition to its acute risks, has the added disadvantage that because the initial
surgery is performed at an early age, reintervention may be necessary. So, aim of this
study was to evaluate the safety, efﬁcacy and in-hospital results of percutaneous
transvenous mitral commissurotomy in young patients with severe rheumatic mitral
stenosis.
Materials and Methods: The study group included 360 consecutive patients who
underwent PTMC at the National Institute of cardiovascular Diseases (NICVD),
Dhaka and Al -Helal Heart Institute, Mirpur, Euro-Bangla Heart Hospital, Lal-
matia, Dhaka between May 2003 and December 2012. Safety, efﬁcacy and in-
hospital results of percutaneous transvenous mitral commissurotomy were analyzed
in 48 patients 20 years old or younger (group 1) and compared with 312 those of
adults (group 2).
Results: Young patients were less frequently in atrial ﬁbrillation (5.9% vs. 32.4%,
P<0.001) and had less mitral valve deformities, echo score: >8 (14.6% vs. 32.4%,
P<0.0001). Mitral valve area index by 2D-echo was of 0.62 0.18cm2/m2in group 1
and 0.610.19cm2/m2in group 2 (P¼ns) and was larger in group 1 (1.54 0.6 cm2/
m2 vs. 1.29 0.5 cm2/m2) after the procedure (P<0.001). Procedural success was
obtained in 47 (97.9%) patients of group 1 vs. 284 (91.02%) patients of group 2
(P<0.001). There was no procedural death in both groups. There are 2 (0.64 %) in
hospital death in group-2 and no death in group-1. In group-2, 1 patient died from
massive CVD after PTMC and 1 patient died from renal failure and electrolyte
imbalance.
Conclusion: Percutaneous transvenous mitral commissurotomy is safe and effective
procedure in young with rheumatic mitral stenosis and provides better immediate
echocardiographic and in-hospital results than in adults.
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Echocardiographic Right Ventricular Function Assessment Before and After Successful
Percutaneous Mitral Commissurotomy
Touﬁqur Rahman
National Institute of Cardiovascular Diseases, Dhaka, DHAKA, Bangladesh
Background: Rheumatic fever and rheumatic heart disease continue to be the major
health problem in all developing countries including Bangladesh. Mitral stenosis (MS)
affects right ventricular (RV) function as a result of myocardial and haemodynamic
factors. Functional analysis of the right ventricle cannot be reliably evaluated by
conventional echocardiography, because of its complex geometry and load dependence
of ejection phase indices.
Aims: To assess right ventricular function before and after successful percutaneous
mitral commissurotomy.
Method: A prospective study was done in NICVD, Dhaka, Bangladesh during the
period of August2007 to May2011. 225 patients with rheumatic mitral stenosis who
underwent PTMC were evaluated by Doppler echocardiography during and 24-48
hours after procedure to assess right ventricular function. A group of 30 healthy age
and gender-matched subjects served as controls. Multiple parameters of global and
longitudinal RV function were assessed by conventional and tissue Doppler imaging
echocardiography. The RV function was evaluated using the Tricuspid Annular Plane
Excursion (TAPSE), the RV Tei index, and systolic myocardial velocities by Doppler
tissue imaging peak isovolumic contraction (DTI(IVC)) and peak systolic (DTI(S)) at
the lateral tricuspid annulus.
Results: After PTMC Mitral Valve Area increased from 0.82 +/- 0.11 cm2 to
1.75 +/- 0.27 cm2 (p <0.01). LA size decreased from 48.27 +/-07.76 mm to
30.25 +/-08.52mm (p <0.05) and Mitral Valve Gradient (MVG) reduced from
26.23+/-5.69 mm Hg to 11.73 +/- 4.25 mm Hg (p<0.01). RV outﬂow tract
fractional shortening (RVOTfs) increased from 55 +/-13% to 71 +/- 13%
(P ¼ 0.002). There was a signiﬁcant decrease in systolic pulmonary artery
pressure from 47.8 +/- 22.5 mmHg to 23.1 +/-11.4 mmHg (P ¼ 0.02), in the
RV Tei index from 0.42+/-0.026 to 0.27+/-0.11 (P ¼ 0.021), in myocardial
acceleration during isovolumic contraction (IVA) at the lateral tricuspid annulus
from 0.35+/-0.12 m/s2 to 0.24+/-0.08 m/s2 (P ¼ 0.022), and in isovolumic
contraction velocities at the lateral tricuspid annulus from 12.06+/-2.67 cm/s to
9.42+/-2.93 cm/s (P¼0.033). In contrast, tissue Doppler velocities at the septal
tricuspid annulus remained unchanged.
Conclusion: Immediately after successful PTMC, signiﬁcant decrease in RV
contractility as assessed by IVA was observed whereas other parameters of infundibular
and global RV function as assessed by RVOTfs and Tei index showed signiﬁcant
improvement.
